Clinical trial
Fosfomycin Versus Standard of Care in Children With Antibiotic-resistant Urinary Tract Infections: A Non-inferiority, Pragmatic, Multi-centre Adaptive Trial to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of Oral Fosfomycin in Children With Antibiotic-resistant Urinary Tract Infections.
NCT05709028 is registered in ClinicalTrials.gov with University of Sydney as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fosfomycin Versus Standard of Care in Children With Antibiotic-resistant Urinary Tract Infections: A Non-inferiority, Pragmatic, Multi-centre Adaptive Trial to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of Oral Fosfomycin in Children With Antibiotic-resistant Urinary Tract Infections.
- Lead sponsor
- University of Sydney
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- August 2, 2023
- Completion date
- August 31, 2027
- Enrollment
- 300 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.